Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CLINICAL UTILITY AND FEASIBILITY OF I-124 PET/CT IMAGING AND DOSIMETRY IN PATIENTS WITH THYROID CANCER

NCT06443866 is registered in ClinicalTrials.gov with Miami Cancer Research Center, Inc. as lead sponsor.

NCT NCT06443866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06443866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CLINICAL UTILITY AND FEASIBILITY OF I-124 PET/CT IMAGING AND DOSIMETRY IN PATIENTS WITH THYROID CANCER
Lead sponsor
Miami Cancer Research Center, Inc.
Phase
Observational
Overall status
Recruiting
Start date
February 1, 2022
Completion date
December 31, 2029
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rai-refractory thyroid cancer, thyroid cancer